Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
W. Wilson+8 more
semanticscholar +1 more source
Ibrutinib-Induced Perianal Rash Complicated by Bacterial Infection in a Patient With Chronic Lymphocytic Leukemia: A Case Report and Literature Review. [PDF]
Singh J+5 more
europepmc +1 more source
Ibrutinib continues to influence the therapeutic landscape of chronic lymphocytic leukemia: new data presented at ASCO 2017 [PDF]
Stefano Molica
openalex +1 more source
PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB VERSUS PLACEBO IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH TREATMENT‐NAÏVE FOLLICULAR LYMPHOMA (PERSPECTIVE) [PDF]
S. Rule+7 more
openalex +1 more source
Immunohistochemical Study of the Localization of Ibrutinib-Protein Conjugates in the Rat Gastrointestinal Tract. [PDF]
Kataoka H+5 more
europepmc +1 more source
IBRUTINIB FOR RELAPSED / REFRACTORY CLL: AN UPDATE OF THE UK AND IRELAND ANALYSIS OF OUTCOMES IN 315 PATIENTS [PDF]
George Follows, U.K. CLL Forum
openalex +1 more source
IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY [PDF]
Christophe Bonnet+11 more
openalex +1 more source
Advancing Mantle Cell Lymphoma Risk Assessment: Navigating a Moving Target. [PDF]
Ferrero S, Ragaini S.
europepmc +1 more source
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia [PDF]
Lian Xu+16 more
openalex +1 more source